Drug Topics

JANUARY 3, 2025

Researchers explored ideas of simplifying the vaccination process to yield higher rates of adult immunization, similar to that of the COVID-19 pandemic.

Vaccines

Pharma Marketing Network

DECEMBER 31, 2024

Table of Contents Sr# Headings 1 Introduction: The Pharma Marketing Challenge 2 Building a Winning Pharma Marketing Strategy 3 The Role of Branded Drug Campaigns 4 Innovating for Future Success Introduction: The Pharma Marketing Challenge Marketing pharmaceuticals is no small feat. In an industry where lives are at stake, creating compelling, compliant, and effective campaigns can feel like walking a tightrope.

FDA

Hospital Pharmacy Europe

DECEMBER 30, 2024

A study looking at the use of potentially inappropriate medications (PIMs) in hospitalised adults aged75 and over has highlighted the need for multidisciplinary interventions to review chronic medications in these patients. The study found that the overall prevalence of PIMs was moderate but varied considerably between hospitals and also revealed a potential missed opportunity to optimise medication use within this setting.

Hospitals

European Pharmaceutical Review

JANUARY 3, 2025

Researchers have developed a high performance liquid chromatography (HPLC) method that enables accurate determination and precise impurity analysis of the adrenergic -receptor blocker Carvedilol. Carvedilol is commonly used drug to treat cardiovascular diseases , Yuan et al. explained. While there are a variety of methods that can detect and quantify carvedilol, these methods often have limitations in terms of sensitivity, selectivity, or the ability to simultaneously quantify carvedilol and its

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

The Checkup by Singlecare

JANUARY 3, 2025

Contrave is a brand-name medication approved by the U.S. Food and Drug Administration (FDA) for chronic (long-term) weight management in certain adults. It should be taken with a reduced-calorie diet and increased physical activity. As a combination drug that contains an opioid antagonist and antidepressant, it affects the brain to make you feel fuller and lower your appetite.

FDA

DiversifyRx

JANUARY 2, 2025

KPI optimization is critical to improving the performance of your independent pharmacy. If you dont measure it, you cant improve itthis statement has never been truer for pharmacy owners. Key Performance Indicators (KPIs) are the benchmarks of success, providing insights into your pharmacys performance and guiding smarter decisions. Yet, many pharmacy owners overlook this critical aspect, focusing on day-to-day operations without a clear picture of their businesss health.

Independent Pharmacies

Pharma Marketing Network

DECEMBER 31, 2024

Table of Contents Sr# Headings 1 Introduction: The Need for Strategy in Healthcare Marketing 2 Crafting a Patient-Centered Marketing Approach 3 Leveraging Digital Tools for Success 4 Future-Proofing Your Healthcare Marketing Strategy Introduction: The Need for Strategy in Healthcare Marketing Building an effective healthcare marketing strategy can feel like solving a complex puzzle.

HIPAA

The Checkup by Singlecare

DECEMBER 30, 2024

Soma, the brand name for the generic medication Carisoprodol, is a muscle relaxant given to those with pain related to musculoskeletal conditions. The prescription drug is part of the skeletal muscle relaxant class of medications. Due to the risk of substance abuse on this medicine, some may wonder if Soma is considered a controlled substance. We went to the medical experts to learn everything you want to know about Soma and its potential for drug abuse.

Controlled Substances

STAT

DECEMBER 30, 2024

Although bipartisan legislation to provide Medicare coverage for obesity treatments has circulated in Congress for more than a decade, the Congressional Budget Office (CBO) ventured to  estimate  the budgetary effects of such a policy for older Americans starting in 2026 for the very first time in a report published in October.  The CBO should be commended for conducting this comprehensive analysis.

Med Ed 101

JANUARY 1, 2025

I’ve compiled this YouTube video to help candidates best prepare for their 2025 BCPS pharmacy exam. Pass rates continue to be in the 60% range so it is difficult to pass this exam. There are significant changes this year in the 2025 BCPS Exam compared to last spring. The content outline has shifted significantly. Here […] The post 2025 BCPS Pharmacy Exam – What You Need To Know appeared first on Med Ed 101.

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

European Pharmaceutical Review

DECEMBER 30, 2024

The use of advanced therapies using cells or genes to achieve significant leaps in medical treatment was perceived as a niche sector just a decade ago, but it has now started to garner a greater level of understanding and recognition in the pharmaceutical industry. Numerous groundbreaking advances have shown these therapies hold potential to revolutionise how we treat, and potentially cure, many conditions, including for patients with underlying genetic or cellular causes of disease that have

Medical Schools

The Checkup by Singlecare

DECEMBER 31, 2024

Prednisone is a medication used to decrease irritation and inflammation in the body. It belongs to a class of drugs called glucocorticoids. There are many different conditions that prednisone is used for, including allergies, asthma, dermatitis, inflammatory bowel disease, arthritis, lymphoma, and leukemia. Its even used for organ transplantation in adults.

Dosage

STAT

DECEMBER 30, 2024

Axsome Therapeutics is moving ahead with plans to submit its Alzheimer’s disease treatment for Food and Drug Administration approval despite mixed results from two new clinical trial readouts.  Axsome, which is based in New York, announced Monday that its drug AXS-05 met the primary endpoint of one trial testing the therapy for agitation caused by Alzheimer’s, but failed to show statistical significance in another.

FDA

Med Ed 101

DECEMBER 29, 2024

Reducing diabetes medications in geriatric patients with low A1c involves careful consideration of the risks and benefits of continued intensive glycemic control. In older adults, particularly those with multiple comorbidities, frailty, or limited life expectancy, maintaining very low A1c levels may increase the risk of adverse outcomes, such as hypoglycemia, which can lead to falls, […] The post Deprescribing in Diabetes – Geriatric Focus appeared first on Med Ed 101.

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

European Pharmaceutical Review

JANUARY 2, 2025

The RNA therapeutics industry stands poised for a transformative 2025, driven by breakthroughs in technology, expanding clinical applications, and a rapidly growing pipeline of innovative therapies. Following the unprecedented speed and success of mRNA-based COVID-19 vaccine development, the field has experienced a surge in investment and research to unlock the powerful potential of RNA for other therapeutic applications.

Vaccines

The Checkup by Singlecare

DECEMBER 30, 2024

Gabapentin is a prescription anticonvulsant drug (aka an anti-seizure medication) and pain medication. It can help treat seizures and relieve anxiety. According to a 2024 study in Animals, gabapentin is also safe and well-tolerated for dogs with behavior disorders. As far as pain management, dogs who have degenerative joint diseases or nerve pain may need gabapentin to treat chronic pain or neuropathic pain.

Dosage

STAT

DECEMBER 30, 2024

Work by device manufacturers to improve the performance of pulse oximeters on people with darker skin has progressed little since the Food and Drug Administration asked manufacturers in 2013 to voluntarily test the devices on more diverse skin tones, according to a study published Monday in JAMA. The study and a related editorial suggest clearer guidance, enforcement, and possibly legal action may be necessary to ensure the devices work well on all skin tones.

Documentation

Drug Topics

DECEMBER 31, 2024

Check out this list of our top 5 most read obesity stories from the year 2024.

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

European Pharmaceutical Review

JANUARY 2, 2025

The National Institute for Health and Care Excellence (NICE) has recommended the first drug for NHS use to prevent cisplatin-induced hearing loss ( ototoxicity ) in children and young people between the ages of one month and 17 years old.Pedmarqsi (anhydrous sodium thiosulfate) is indicated for these children who have localised, non-metastatic, solid tumours.

Chemotherapy

The Checkup by Singlecare

DECEMBER 30, 2024

Veterinarians do not use the skeletal muscle relaxant tizanidine in dogs. There are no veterinary studies on the effects or safety of tizanidine in companion animals and no published dosages. If a dog is given or accidentally eats tizanidine, thats a potential veterinary emergency requiring inducing vomiting or monitoring the dog in a veterinary clinic.

Dosage

STAT

JANUARY 2, 2025

The new year ushered in a final slate of updates to the federal rules for how hospitals have to disclose their prices, and experts are optimistic the changes will make the data more helpful in identifying less expensive providers.   The updates are fairly straightforward. The government is requiring hospitals to include additional pieces of data to improve their consistency and make it easier to compare across hospitals.

Hospitals

Drug Topics

DECEMBER 28, 2024

Check out this list of our top 5 most read infectious disease stories from the year 2024.

PharmaVoice

JANUARY 2, 2025

A handful of innovative startups are scrambling to gain a foothold as technology improves at a rapid clip.

The Checkup by Singlecare

DECEMBER 30, 2024

Most people have heard the brand name Valium. Diazepam is the generic version. Veterinarians commonly use it as a sedative, anxiety treatment , seizure medication , and muscle relaxant in cats and dogs. Its often used on an as-needed basis, but veterinarians are cautious about giving cats diazepam on a daily basis. Some cats can experience life-threatening liver injury when taking daily oral diazepam.

Dosage

STAT

JANUARY 3, 2025

Life was getting better for Carlos Campos, 72, a retired machinist who lives with his wife and daughter in Tukwila, Wash. Diagnosed about 20 years ago with type 2 diabetes, he was delighted to see his blood sugar levels improve dramatically about a year ago, when he started taking Ozempic.  Every week, in hour-long appointments, he shared his improved numbers via his continuous glucose monitor’s app with Maureen Chomko, a diabetes educator who works with his primary care physician at

Drug Topics

JANUARY 3, 2025

Researchers aimed to identify the barriers impeding HPV vaccine uptake since 2019 among US mid-adults aged 27 to 45.

Vaccines

PharmaVoice

JANUARY 3, 2025

Pharma companies stepped up to support The Carter Center and provide access to life-saving treatments.

The Checkup by Singlecare

DECEMBER 31, 2024

Prednisone is an FDA-approved prescription medication to treat a range of common conditions characterized by inflammation caused by the immune system. It belongs to a class of drugs called corticosteroids (sometimes called glucocorticoids ). Like other steroids, prednisone reduces swelling, redness, and other symptoms caused by immune system reactions.

Dosage

Pharmacy Times

DECEMBER 31, 2024

Bispecific antibodies amivantamab and tarlatamab hold promise for patients.

Drug Topics

JANUARY 3, 2025

A study found that sending a letter to providers about standards of care and glucagon preparations could increase glucagon prescription rates.

Fierce Healthcare

JANUARY 3, 2025

Mimicking prior federal and state investigations into drug manufacturers, health insurer Aetna is suing in Connecticut for rigging the generic drug market.

Insurance

The Checkup by Singlecare

DECEMBER 30, 2024

It is strongly recommended that people with Type 1 or Type 2 diabetes , or gestational diabetes , frequently monitor their blood glucose (sugar) levels at home. Some use a blood glucose meter which requires a finger stick, while others prefer using a continuous glucose monitor (CGM). A popular personal CGM system is the FreeStyle Libre 3 Plus sensor.

Insurance

Pharmacy Times

JANUARY 2, 2025

Over 70% of children and young people with long COVID reported improvements in their symptoms within 24 months of their initial positive SARS-CoV-2 test.